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was associated with most adipokines. HDL, but not TC, was 
also associated with some adipokines. TG were only associ-
ated with adiponectin. Associations were mostly related to 
adiposity.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 In children and adults, the association between obe-
sity and the presence of cardiovascular disease risk fac-
tors and insulin resistance is well established  [1–4] . How-
ever, the mechanisms relating adiposity to the atheroscle-
rotic process are still under study  [5] . One of several 
proposed hypotheses is that adipose tissue acts as a secre-
tory gland releasing hormones and adipokines with pro- 
or anti-inflammatory activity  [5, 6] . These adipokines in 
turn affect either glucose or fat transport/utilization, tri-
glycerides (TG) production, or endothelial function in a 
negative or positive way  [5, 7–10] .
 Tumor necrosis factor-  (TNF-  ), adiponectin, and 
resistin have been previously associated with insulin re-
sistance and obesity in youth  [11] , as well as other cardio-
vascular disease risk factors such as blood pressure (BP) 
 [12–14] . Elevated interleukin-6 (IL-6) concentrations 
have been associated with cardiovascular disease in 
adults  [15] and higher IL-6 concentrations appear to be 
 Key Words 
 Blood pressure   Cytokines   Lipids   Obesity   Adolescents 
 Abstract 
 This study evaluated the associations of adipokines with
cardiovascular risk factors.  Subjects/Methods: 60 normal 
weight (BMI  ̂  75th percentile) and 60 overweight (BMI 
 6 95th percentile) adolescents aged 10–14 years. Resting 
systolic and diastolic blood pressures (SBP, DBP) and waist 
circumference were obtained in duplicate. Circulating adi-
ponectin, resistin, tumor necrosis factor-  (TNF-  ), interleu-
kin-6 (IL-6), total cholesterol (TC), high-density lipoprotein 
(HDL), and triglycerides (TG) were measured from fasting 
plasma samples.  Results: Simple correlations showed that 
SBP was significantly related (p  ! 0.05) to adiponectin (r = 
–0.185), resistin (r = 0.207), and IL-6 (r = 0.238); HDL was sig-
nificantly related to adiponectin (r = 0.398) and TNF-  (r = 
–0.227). TG was only related to adiponectin (r = –0.292, p  ! 
0.05). Multiple regression models controlling for puberty 
and ethnicity indicated that adiponectin (R 2 = 0.152, p  ! 
0.05), resistin (R 2 = 0.152, p  ! 0.05), and IL-6 (R 2 = 0.170, p  ! 
0.05) were associated with SBP. The association between
adiponectin and HDL was stronger in normal weight versus 
overweight adolescents (R 2 = 0.336, p  ! 0.05). None of the 
other models showed differences in the associations by 
weight status.  Conclusions: In adolescents, SBP but not DBP 
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present in youth with the metabolic syndrome  [3] . Data 
is also present suggesting that some of these associations 
are dependent on adiposity levels  [11, 14] . However, no 
study has demonstrated associations of resistin with BP 
or lipids in youth  [16] .
 Although several studies have been conducted to date 
on this topic, most of the previous studies in children
focused on a particular adipokine, mostly adiponectin. 
Moreover, given the interrelationship between insulin
resistance and cardiovascular disease  [1, 5, 7] , it would
be expected that adipokines related to insulin resistance 
are associated with other cardiovascular risk factors.
The purpose of this study is twofold: first to evaluate the 
associations between different adipokines and BP and 
blood lipids, and second to evaluate if these associations 
are attenuated by overall or abdominal adiposity or de-
pendent on weight status. We hypothesized that TNF-  , 
IL-6, and resistin would be positively associated with 
 systolic blood pressure (SBP), TG, total cholesterol (TC), 
and negatively associated with high-density lipoprotein 
(HDL). In contrast, adiponectin would be negatively as-
sociated with SBP, TG, TC, and positively associated with 
HDL. Furthermore, these relationships would be exacer-
bated in overweight adolescents and attenuated by adi-
posity.
 Subjects and Methods 
 Subjects 
 Data from 120 adolescents (60 girls and 60 boys), aged 10–14 
years who participated in the Cardiovascular Health in Children 
and Youth (CHIC III) Study between 2000 and 2003, were uti-
lized for this retrospective study. The CHIC studies have been 
multi-cohort studies, focused on cardiovascular risk factors in 
school-aged youth  [17, 18] . All subjects signed an assent and their 
parents or guardians signed an informed consent approved by 
the institutional review board of the institution. Potential sub-
jects for this analysis had to be in pubertal developmental stages 
2–4 (mid-puberty) and have normal glucose concentrations 
(fasting glucose  ! 5.6 mmol/l). All subjects meeting the pre-
scribed criteria were included in the subject pool. Body mass in-
dex (BMI) percentiles by age and sex were used to classify youth 
into obese and normal weight categories  [19] . BMI percentile was 
chosen because it is the standard clinical criteria in the USA for 
determination of weight status  [19] . The 75th and 95th percentile 
thresholds were chosen to maximize differences in adiposity be-
tween the normal weight and overweight groups. From the sub-
ject pool, a subset was identified which included those with a BMI 
 ̂  75th percentile (normal weight) and those with BMI  6 95th 
percentile (overweight). From this subset 60 normal weight and 
60 overweight subjects were randomly selected based on their sex 
using the select random cases procedure of the Statistical Pack-
age for Social Sciences for Windows version 9.0 (SPSS Inc., Chi-
cago, Ill., USA). 60 subjects per group were sufficient to detect 
group differences of 0.4 ng/ml for TNF-  , 0.6 ng/ml for IL-6, 2.1 
ng/ml for resistin and 1.6 mg/ml for adiponectin, with an   = 
0.05,   = 0.2 and a power of 80%.
 Anthropometric, Pubertal Status and BP Measurements 
 Measurements took place in the school setting within 3 days 
of blood sampling. The subjects were dressed in shorts and T-
shirts without shoes. Height was measured to the nearest 0.1 cm 
using a stadiometer (Perspective Enterprises, Kalamazoo, Mich., 
USA) and body mass was obtained in kilograms to the nearest 0.1 
kg using a Scale-Tronix electronic scale (model 5602; Scale-Tro-
nix, Carol Stream, Ill., USA). BMI was computed using body 
mass in kilograms divided by height in meters squared (BMI = 
kg/m 2 ) and used as an indicator of overall adiposity.  Waist cir-
cumference was measured in duplicate to the nearest 0.1 cm us-
ing a tape with tensiometer (Gulick Tape; Country Technologies 
Inc., Gays Mill, Wisc., USA) and was used as an indicator of ab-
dominal adiposity. All measurements were obtained following 
procedures described by the National Health and Nutrition Ex-
amination Survey  [20] . Puberty was determined using a validat-
ed self-completed questionnaire that assessed puberty based on 
growth spurt in height, pubic hair development, skin changes in 
both boys and girls, facial hair growth and voice change in boys 
only, and breast development and menarche in girls  [21] . Ethnic-
ity was self-reported.
 After the anthropometric measures were obtained the subjects 
sat for 5 min before BP was measured using a random-zero mer-
cury sphygmomanometer and appropriately sized cuff (Baum 
Inc., Copiague, N.Y., USA). BP readings were obtained in dupli-
cate in the right arm following American Heart Association pro-
cedures. If the pressure readings differed by  6 10 mm Hg, a third 
reading was taken and the three readings averaged.
 Blood Sampling and Analyses 
 Blood samples were obtained after an overnight fast, between 
7 and 9 a.m., at the school, using sterile venipuncture technique. 
Fasting compliance was verbally verified by on-site research as-
sistants. Blood samples were collected in tubes containing EDTA 
and immediately centrifuged to obtain plasma. Plasma was ali-
quoted, maintained in dry ice and transported to the laboratory 
where it was kept frozen at –80  °  C until analyzed. Concentrations 
of TC, HDL cholesterol and TG were tested on fasting plasma 
samples using automated coupled-enzymatic procedures and a 
Hitachi 911 analyzer (Boehringer-Mannheim Corp.) by a CLIA-
approved clinical laboratory.
 Concentrations of plasma of the adipokines resistin, TNF-  , 
IL-6, and adiponectin were measured using standard enzyme im-
munoassay procedures (Linco Research Inc., St. Charles, Mo., and 
R&D Systems, Minneapolis, Minn., USA). The resistin assay had 
a sensitivity of 0.5 ng/ml with intra- and inter-assay coefficients 
of variation of  ! 10 and 11.2%, respectively. The adiponectin assay 
had a limit of sensitivity of 0.78 ng/ml with intra- and inter-assay 
coefficients of variation of  ! 10 and 11.6%, respectively. The TNF-
  kit had a sensitivity of 0.5 pg/ml while the IL-6 kit had a sensi-
tivity of 0.2 pg/ml. The intra-assay coefficient of variation for 
TNF-  and IL-6 was  ! 10%. The inter-assay coefficient of varia-
tion for TNF-  was 12.2% and for IL- 6 was 18.2%.
 Adipokines and Cardiometabolic Factors 
in Adolescents 
 Horm Res Paediatr 2011;76:123–129 125
 Statistical Analysis 
 For descriptive purposes, mean and standard deviations 
were computed for all variables by weight groups. Since the adi-
pokines and lipid concentrations were not normally distributed, 
their values were transformed using the natural log. To deter-
mine the associations between SBP, lipids and each adipokine, 
analyses were conducted in three steps. First, we computed bi-
variate correlations between BP, lipids, and all adipokines. Sec-
ond, for those associations that were statistically significant we 
tested several multiple regression models. The first model in-
cluded the risk factor (SBP, TC, HDL, or TG) and one adipokine 
controlling for ethnicity (African-American, Caucasian and 
other), sex, age or puberty. Only control variables that were sig-
nificantly associated with the dependent variable in this first 
model were kept in subsequent models. The second model was 
computed to evaluate if the association between the risk factor 
and the adipokine was attenuated by abdominal adiposity (waist 
circumference). The third model was computed to evaluate if the 
association was present depending on the weight status of the 
adolescents and included an interaction term between the adi-
pokines and weight status. Weight status was based on the BMI 
percentile ( ̂  75th and  6 95th percentile) indicating normal 
weight or obesity. Interaction terms not statistically significant 
were excluded from the models presented. Statistical signifi-
cance was held at p  ! 0.05. Analyses were conducted using SPSS 
for Windows version 9.0.
 Results 
 Subjects’ Characteristics 
 The subjects’ characteristics are presented in  table  1 
by weight groups. Racial distribution was 57% African-
American, 37% Caucasian, and 6% other races including 
Native American, Asian and other. 29 participants were in 
pubertal stage 2, 53 were in pubertal stage 3, and 38 were 
in pubertal stage 4. The overweight group was taller and 
slightly advanced in pubertal status than the normal 
weight group. In addition, some cardiovascular risk factors 
and adipokine concentrations were significantly (p  ! 0.05) 
different between normal and overweight adolescents.
 Bivariate Correlations in the Whole Cohort 
 SBP was significantly (p  ! 0.05) related to adiponectin 
(r = –0.185), resistin (r = 0.207), and IL-6 (r = 0.238). Dia-
stolic blood pressure (DBP) was not related to any adipo-
kine (p  1 0.05). HDL was significantly (p  ! 0.05) associ-
ated with adiponectin (r = 0.398) and TNF-  (r = –0.227), 
while TG were only associated with adiponectin (r = 
–0.292; p  ! 0.05). No other significant associations were 
obtained.
Table 1. A nthropometric and metabolic characteristics of subjects by weight status groups: mean 8 SD (mini-
mum–maximum)
Normal weight (n = 60) Overweight (n = 60)
Physical
Female/male 30/30 30/30
Age, years 12.081.0 (10–14) 12.081.0 (11–14)
Puberty (stages 1–5) 2.980.7 (2–4) 3.280.7* ( 2–4)
Stature, cm 152.187.6 (135.4–170.3) 159.887.9* (144.7–186)
Body mass, kg 40.485.9 (26.7–56.6) 76.3815.2* (52.4–123)
BMI 17.481.4 (13.6–20.1) 29.785.0* (23.7–46.4)
Waist, cm 61.785.3 (52.3–80.2) 90.0810.5* (70.1–118.8)
CVR risk factors
SBP, mm Hg 103810 (85–120) 113811* (93–143)
DBP, mm Hg 65811 (36–89) 66810 (43–99)
TC, mg/dl 154.6825.3 (102–258) 150.7829.2 (107–267)
HDL, mg/dl 52.5810.7 (34–87) 40.688.3* (24–58)
TG, mg/dl 61.9825.8 (25–155) 86.7839.1* (27–189)
Adipokines
Adiponectin, g/ml 12.585.0 (4.4–30.4) 7.683.4* (2.9–19.4)
Resistin, ng/ml 10.284.0 (3.7–22.3) 11.386.0 (4.4–41.3)
TNF-, pg/ml 1.480.7 (0.2–3.8) 1.981.4* (0.3–7.2)
IL-6, pg/ml 1.581.6 (0.1–6.4) 1.882.0 (0.2–9.6)
* p < 0.05 for weight status groups (normal weight vs. overweight).
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 Multiple Regression Analyses 
 Regression analyses were conducted only for SBP, 
HDL, TG and the adipokines that were significantly re-
lated to them in the bivariate analyses. For each param-
eter, several separate regression models were tested; ini-
tially all control variables were included in the first
model but only significant ones were kept in subsequent 
models. All regression models for SBP included puberty 
and ethnicity as control variables. HDL and TG models 
did not include control variables. The standardized   -
coefficients  8 SE are presented for each adipokine as 
well as the total R 2  8 SE for the regression model. For 
SBP, the models containing adiponectin, resistin and 
IL-6 were significant ( table 2 A). Waist circumference at-
tenuated all associations (p  ! 0.001) and so did weight 
status (p  ! 0.001). HDL was significantly associated with 
adiponectin, presenting a significant interaction term 
between  adiponectin  and weight status (p = 0.033). HDL 
was negatively associated with TNF-  (p = 0.021), but the 
association became attenuated when waist circumfer-
ence or weight status were included in the model (p = 
0.087 and p = 0.229, respectively). TG were also associ-
ated with adiponectin, but the weight status interaction 
was not significant (p  1 0.05). Both waist circumference 
and weight status attenuated this last association ( ta-
ble 2 B).
 Discussion 
 We evaluated the associations between BP and lipids 
and 4 adipokines. SBP was associated with adiponectin, 
resistin and IL-6. HDL was related to adiponectin and 
TNF-  , while TG were only associated with adiponectin. 
DBP and TC were not significantly associated with any 
adipokine in the participating youth. The associations 
obtained in our study were significant but not very strong. 
Since stronger associations have been reported in adults 
 [15, 22–24] , the weak associations may be simply due to 
the fact that adolescents have not had sufficient time to 
fully develop the relationships.
 Some research has shown that increased adiponectin 
is associated with lower SBPs  [13, 25] . In vitro, adiponec-
tin reduces monocyte adhesion in endothelial cells, pre-
venting the development of lesions in the endothelium 
 [10] . It also prevents increases in the intima media thick-
Table 2A. M ultivariate regression models for the relationships be-





p Model R2 p
Adiponectin –0.195 0.028 0.152 0.001
Adiponectin 0.038 0.677
Waist 0.463 0.000 0.308 0.000
Adiponectin 0.003 0.975
Weight status 0.382 0.000 0.253 0.000
Resistin 0.147 0.110 0.152 0.002
Resistin 0.079 0.343
Waist 0.426 0.000 0.308 0.000
Resistin 0.107 0.214
Weight status 0.361 0.000 0.258 0.000
IL-6 0.246 0.008 0.170 0.000
IL-6 0.134 0.103
Waist 0.420 0.000 0.330 0.000
IL-6 0.177 0.035
Weight status 0.363 0.000 0.289 0.000
S ignificant models presented.
Weight status coding: normal = 0 (BMI <75th percentile); 
overweight = 1 (BMI >95th percentile).
All cytokines were logarithmically transformed.
Table 2B. M ultivariate regression models for the relationships be-







Adiponectin 0.390 0.000 0.152 0 .000
Ad iponectin 0.146 0.097
Waist –0.489 0.000 0.332 0.000
Adiponectin 0.339 0.009
Weight status 0.434 0.312
Adiponectin and weight status –0.830 0.033 0.336 0.000
TNF- –0.216 0.021 0.046 0.021
TNF- –0.136 0.087
Waist –0.535 0.000 0.327 0.000
TNF- –0.099 0.229
Weight status –0.511 0.000 0.294 0.000
Triglyceride model
Adiponectin –0.350 0.000 0.176 0.000
Adiponectin –0.142 0.162
Weight status 0.282 0.006 0.142 0.000
Adiponectin –0.119 0.224
Waist 0.346 0.001 0.175 0.000
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ness modulating smooth muscle proliferation  [26] . There-
fore, the negative associations between SBP and this adi-
pokine are not surprising. The positive associations be-
tween SBP and resistin and IL-6 are novel findings in 
youth. Gilardini et al.  [27] failed to demonstrate an asso-
ciation between ambulatory SBP and IL-6 in obese young 
children. However, the positive association found in the 
present study appears reasonable since studies in youth 
with obesity of varying degrees and metabolic syndrome 
have shown elevations of IL-6 concentrations compared 
to normal weight youth  [3] .
 Moon et al.  [14] showed a positive association of TNF-
  with BP in older obese adolescents, but we did not. 
TNF-  appears to suppress the release of nitric oxide (a 
vasodilator), therefore increasing total peripheral resis-
tance and BP  [28] . Our sample included both normal 
weight and overweight younger adolescents. Perhaps in 
obese youth this association manifests itself with increas-
ing age.
 The overweight adolescents had higher circulating 
concentrations of TG and low levels of HDL than the nor-
mal weight adolescents. Concomitantly, we found a posi-
tive association between HDL and adiponectin and a neg-
ative association between TG and adiponectin. These re-
sults support previous findings by Huang et al.  [29] and 
Bacha et al.  [25] . Interestingly, the association between 
adiponectin and HDL was stronger in normal weight ad-
olescents, perhaps because these adolescents had higher 
HDL concentrations as well as higher adiponectin con-
centrations. The negative association between adiponec-
tin and TG could potentially be related to the fact that 
adiponectin has been shown to inhibit TG production by 
the liver  [8] .
 Van Gaal et al.  [5] suggested that visceral fat produc-
tion of IL-6 and TNF-  , as part of the inflammatory pro-
cess, affects liver production of lipids. TNF-  is associ-
ated with increased TG production, and a decrease in li-
poprotein lipase  [30] . IL-6 in turn stimulates the release 
of very-low-density lipoproteins which can become oxi-
dized to low-density lipoprotein. Moon et al.  [14] showed 
a positive association between TNF-  and TG in obese 
adolescents and we showed a negative association with 
HDL further expanding on the relationship between 
TNF-  and dyslipidemia.
 To our knowledge, no other studies have shown asso-
ciations between lipids and resistin in youth. However,
in adults, resistin was positively associated with TG and 
negatively with HDL concentrations  [24] . In mice, resis-
tin has been related to increased hepatic lipogenesis and 
very-low-density lipoproteins export  [31] . Because the 
average values of lipids are lower in youth than adults 
 [32] , it is possible that the relationship between resistin 
and lipids becomes evident at older ages when dyslipid-
emia is more prevalent. The relationship between lipids 
and IL-6, in particular between IL-6 and TG, has only 
been recently shown in obese adolescents but not in nor-
mal weight or overweight adolescents  [33] . Interestingly, 
previous studies in adults did not show such an associa-
tion  [22, 23] . Probably since our study included normal 
weight and obese adolescents, we did not detect this as-
sociation either.
 We and others have previously demonstrated small 
(  20%) differences in these adipokine concentrations be-
tween overweight and normal weight youth  [3, 14, 29, 34] . 
Therefore, as our data suggest, the associations between 
these adipokines and cardiovascular risk factors in youth 
are dependent on adiposity, as associations were attenu-
ated when including adiposity surrogates in the regres-
sion models. We also know that BP is related to stature as 
well as adiposity and our overweight group was taller 
than our normal weight group ( table 1 ). Our data, not re-
ported here, suggests that the relationship between BP 
and weight is stronger than the relationship between BP 
and height. Furthermore, there is strong collinearity be-
tween height and weight; thus we chose not to adjust our 
BP analysis for height.
 The adipose tissue is one source of all these adipokines 
 [6, 28, 35, 36] and adiponectin is produced solely by the 
adipocyte. In contrast, TNF-  , IL-6 and resistin are also 
produced by the muscle and immune system cells  [6, 28, 
35] . Since the prevalence of cardiovascular risk factors is 
higher with increased adiposity, the associations between 
this particular adipokine and risk factors is perhaps more 
consistent  [11, 25, 29] . A potential hypothesis is that adi-
pokines explain part of the inter-individual variability
of BP or blood lipids not already explained by adiposity 
(BMI or waist circumference). Although our data does 
not allow us to test this hypothesis, we can suggest that in 
youth any influence of the adipokines is, in most cases, 
dependent on adiposity.
 This study was conducted in previously collected 
blood samples. There was no control in the day-to-day 
variation in adipokine concentrations, however they were 
within ranges of previously published concentrations in 
youth  [3, 12, 14, 25, 29] . The even sample size of normal 
weight and overweight subjects allowed inferences on the 
role of weight status in the studied associations. However, 
this sample characteristic may have limited the results 
with respect to the cardiovascular risk factors, as their 
prevalence increases with increased adiposity.
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 Conclusion 
 The understanding of the roles of these adipokines is 
still a work in progress. We extended the knowledge by 
showing associations not only between adiponectin and 
BP or lipids, but also resistin, TNF-  and IL-6. SBP was 
related to most of the adipokines evaluated in this study. 
Higher SBP was associated with higher resistin and IL-6 
concentrations and lower adiponectin concentrations. 
Higher HDL was associated with lower TNF-  and high-
er adiponectin concentrations while lower TG were asso-
ciated with higher adiponectin concentrations. Neither 
DBP nor TC were related to any of the adipokines. The 
available evidence suggests that increased adiposity medi-
ates these associations between adipokines and cardiovas-
cular risk factors during adolescence as most associations 
were attenuated by waist circumference or weight status.
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